Oppenheimer Lowers Denali Therapeutics (NASDAQ:DNLI) Price Target to $42.00
Denali Therapeutics (NASDAQ:DNLI – Free Report) had its price objective cut by Oppenheimer from $50.00 to $42.00 in a research note issued to investors on Monday,Benzinga reports. They currently have an outperform rating on the stock. A number of other equities research analysts have also issued reports on DNLI. HC Wainwright upped their target price […]
Denali Therapeutics (NASDAQ:DNLI – Free Report) had its price objective cut by Oppenheimer from $50.00 to $42.00 in a research note issued to investors on Monday,Benzinga reports. They currently have an outperform rating on the stock. A number of other equities research analysts have also issued reports on DNLI. HC Wainwright upped their target price […]
